JP2014533689A5 - - Google Patents

Download PDF

Info

Publication number
JP2014533689A5
JP2014533689A5 JP2014542296A JP2014542296A JP2014533689A5 JP 2014533689 A5 JP2014533689 A5 JP 2014533689A5 JP 2014542296 A JP2014542296 A JP 2014542296A JP 2014542296 A JP2014542296 A JP 2014542296A JP 2014533689 A5 JP2014533689 A5 JP 2014533689A5
Authority
JP
Japan
Prior art keywords
composition
glutamine
month
taken orally
body weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014542296A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014533689A (ja
JP6089042B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/000557 external-priority patent/WO2013077893A1/en
Publication of JP2014533689A publication Critical patent/JP2014533689A/ja
Publication of JP2014533689A5 publication Critical patent/JP2014533689A5/ja
Application granted granted Critical
Publication of JP6089042B2 publication Critical patent/JP6089042B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014542296A 2011-11-21 2012-11-17 糖尿病及び関連症状の治療のための方法及び組成物 Expired - Fee Related JP6089042B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161629633P 2011-11-21 2011-11-21
US61/629,633 2011-11-21
PCT/US2012/000557 WO2013077893A1 (en) 2011-11-21 2012-11-17 Methods and compositions for the treatment of diabetes and related symptoms

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016207931A Division JP6389495B2 (ja) 2011-11-21 2016-10-24 糖尿病及び関連症状の治療のための方法及び組成物

Publications (3)

Publication Number Publication Date
JP2014533689A JP2014533689A (ja) 2014-12-15
JP2014533689A5 true JP2014533689A5 (enExample) 2015-01-29
JP6089042B2 JP6089042B2 (ja) 2017-03-01

Family

ID=48470183

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2014542296A Expired - Fee Related JP6089042B2 (ja) 2011-11-21 2012-11-17 糖尿病及び関連症状の治療のための方法及び組成物
JP2016207931A Expired - Fee Related JP6389495B2 (ja) 2011-11-21 2016-10-24 糖尿病及び関連症状の治療のための方法及び組成物
JP2018041934A Expired - Fee Related JP6550160B2 (ja) 2011-11-21 2018-03-08 糖尿病及び関連症状の治療のための方法及び組成物
JP2018153440A Pending JP2018199692A (ja) 2011-11-21 2018-08-17 糖尿病及び関連症状の治療のための方法及び組成物

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2016207931A Expired - Fee Related JP6389495B2 (ja) 2011-11-21 2016-10-24 糖尿病及び関連症状の治療のための方法及び組成物
JP2018041934A Expired - Fee Related JP6550160B2 (ja) 2011-11-21 2018-03-08 糖尿病及び関連症状の治療のための方法及び組成物
JP2018153440A Pending JP2018199692A (ja) 2011-11-21 2018-08-17 糖尿病及び関連症状の治療のための方法及び組成物

Country Status (10)

Country Link
US (2) US20130143968A1 (enExample)
EP (2) EP3437649A1 (enExample)
JP (4) JP6089042B2 (enExample)
CN (3) CN108354916A (enExample)
BR (1) BR112014011898A2 (enExample)
ES (1) ES2785094T3 (enExample)
HK (1) HK1257401A1 (enExample)
IN (1) IN2014KN01037A (enExample)
PH (2) PH12020550726B1 (enExample)
WO (1) WO2013077893A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
US10682325B2 (en) 2017-08-14 2020-06-16 Axcella Health Inc. Compositions and methods for the treatment of liver diseases and disorders associated with one or both of hyperammonemia or muscle wasting
JP2021527670A (ja) 2018-06-20 2021-10-14 アクセラ・ヘルス・インコーポレイテッドＡｘｃｅｌｌａ Ｈｅａｌｔｈ Ｉｎｃ． 筋肉中の脂肪浸潤の治療のための組成物及び方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6031000A (en) * 1998-06-23 2000-02-29 Iowa State University Research Foundation, Inc. Composition comprising β-hydroxy-β-methylbutyric acid and at least one amino acid and methods of use
CA2418543A1 (en) * 2001-06-27 2003-01-09 Probiodrug Ag New dipeptidyl peptidase iv inhibitors and their uses as anti-cancer agents
SE0201713D0 (sv) * 2001-11-23 2002-06-06 Gramineer Internat Ab New methods and use III
TWI351278B (en) * 2002-03-01 2011-11-01 Nisshin Pharma Inc Agent for preventing and treating of liver disease
US20070025953A1 (en) * 2005-07-27 2007-02-01 Jones Michael R Co-therapy for diabetic conditions
CA2774197A1 (en) * 2006-04-22 2008-04-03 Harbor Biosciences, Inc. Drugs and uses to modulate inflammation, metabolic disorders and other conditions
WO2008038771A1 (en) * 2006-09-29 2008-04-03 Ajinomoto Co., Inc. Glutamine-containing composition for increasing blood flow
US20080221074A1 (en) * 2006-11-17 2008-09-11 Jaime Flores-Riveros Drug Screen and Treatment Method
EP2057905A1 (en) * 2007-11-12 2009-05-13 TIMA Foundation Composition for moderating Triglyceride and Cholesterol Levels
WO2010081079A2 (en) * 2009-01-12 2010-07-15 Biokier Inc. Composition and method for treatment of diabetes
NL1036746C2 (nl) * 2009-03-20 2010-09-21 Glnp Holding B.V. Kit van onderdelen bevattende l-glutamine en egcg.
JP2013505936A (ja) * 2009-09-23 2013-02-21 バイオキアー・インコーポレイテッド 糖尿病の治療のための組成物および方法

Similar Documents

Publication Publication Date Title
JP2011522896A5 (enExample)
NZ778131A (en) Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
HK1204272A1 (en) Methods of treating pediatric metabolic syndrome
JP2010195825A5 (enExample)
ECSP13012668A (es) Ácidos 1-bencilcicloalquilcarboxílicos sustituidos y su uso
RU2018111327A (ru) Способ ингибирования всасывания и/или повышения выведения липидов с использованием d-псикозы
WO2011107749A3 (en) Pulsatile drug release
JP2011500690A5 (enExample)
JP2013525444A5 (enExample)
PH12015500407A1 (en) Methods of treating hypertriglyceridemia
NZ743706A (en) Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
JP2015503593A5 (enExample)
HRP20240168T1 (hr) Kombinacije dolutegravira i lamivudina za liječenje hiv infekcije
WO2013103919A8 (en) Compositions and methods for treating metabolic disorders
JP2012036176A5 (enExample)
MX352647B (es) Metodo para temporizar una colonoscopia en donde se administra una composicion de picosulfato.
PH12013500923A1 (en) Compositions of rotigotine, derivatives thereof, or pharmaceutically acceptable salts of rotigotine or its derivative
ES2445846R1 (es) Una composición de combinación farmacéutica y su uso para preparar un medicamento destinado al tatamiento de la diabetes de tipo l y los trastornos metabólicos
HRP20240115T1 (hr) Povećavanje bioraspoloživosti lijeka u terapiji naltreksonom
WO2015038552A3 (en) Aspirin formulation for increased efficacy
WO2011089234A8 (en) Aqueous solution comprising 3-quinuclidinones for the treatment of hyperproliferative, autoimmune and heart disease
JP2014533689A5 (enExample)
JP2015512948A5 (enExample)
JP2014533256A5 (enExample)
JP2015500340A5 (enExample)